Ziprasidone-induced tardive laryngeal dystonia: a case report

Gen Hosp Psychiatry. 2008 May-Jun;30(3):277-9. doi: 10.1016/j.genhosppsych.2007.08.012.

Abstract

Tardive laryngeal dystonia, a rare form of dystonic syndrome, was only reported to be induced by typical antipsychotics. Here, we report one case of ziprasidone-induced tardive laryngeal dystonia in a schizophrenic female patient, who showed dysphonia, hoarseness and dyspnea after taking ziprasidone 120 mg/day for 8 months. These symptoms were significantly improved after discontinuing ziprasidone and increasing the dose of trihexyphenidyl for 1 week. Although atypical antipsychotics are associated with a lower risk of extrapyramidal symptoms, caution should be taken for any tardive dystonic movement when using these medications.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiparkinson Agents / therapeutic use
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Dyspnea / chemically induced
  • Dyspnea / diagnosis
  • Dystonia / chemically induced*
  • Dystonia / diagnosis
  • Female
  • Hoarseness / chemically induced
  • Hoarseness / diagnosis
  • Humans
  • Laryngeal Diseases / chemically induced*
  • Laryngeal Diseases / diagnosis
  • Piperazines / adverse effects*
  • Piperazines / therapeutic use
  • Schizophrenia, Paranoid / drug therapy*
  • Thiazoles / adverse effects*
  • Thiazoles / therapeutic use
  • Trihexyphenidyl / therapeutic use
  • Voice Disorders / chemically induced
  • Voice Disorders / diagnosis

Substances

  • Antiparkinson Agents
  • Antipsychotic Agents
  • Piperazines
  • Thiazoles
  • Trihexyphenidyl
  • ziprasidone